VYNE Therapeutics Inc. SC 13G and SC 13G/A reports

Location
685 Route 202/206 N., Suite 301, Bridgewater, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
5/10/2024, 04:10 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Feb 2, 2024
SC 13G Report SC 13G Nov 13, 2023
SC 13G Report SC 13G Nov 13, 2023
SC 13G Report Nov 13, 2023
SC 13G Report SCHEDULE 13G Nov 2, 2023
SC 13G/A Report SC 13G/A Feb 15, 2022
SC 13G/A Report SC 13G/A Aug 25, 2021
SC 13G/A Report Jul 12, 2021
SC 13G/A Report Feb 16, 2021
SC 13G/A Report SC 13G/A Feb 16, 2021
SC 13G/A Report SCHEDULE 13G (AMENDMENT #1) Feb 16, 2021
SC 13G/A Report Feb 16, 2021
SC 13G/A Report JANUS HENDERSON GROUP PLC OWNS 0.0% Feb 11, 2021
SC 13G Report Feb 2, 2021
SC 13G Report SC 13G Jun 11, 2020
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Jun 11, 2020
SC 13G/A Report Feb 14, 2020
SC 13G/A Report JANUS HENDERSON GROUP PLC OWNS 5.3% OF MENLO Feb 13, 2020
SC 13G/A Report NONE Feb 4, 2020
SC 13G Report SCHEDULE 13G Jan 21, 2020
SC 13G/A Report Feb 14, 2019
SC 13G Report SC 13G Feb 14, 2019
SC 13G/A Report Feb 13, 2019
SC 13G/A Report JANUS HENDERSON GROUP PLC ANNUAL AMENDMENT Feb 12, 2019
SC 13G Report NONE Feb 11, 2019
SC 13G/A Report SC 13G/A Jan 7, 2019
SC 13G Report Aug 13, 2018
SC 13G Report JANUS HENDERSON GROUP PLC OWNS 10.1% OF MENLO May 10, 2018
SC 13G Report SC 13G Feb 8, 2018
SC 13G Report SC 13G Feb 2, 2018
SC 13G Report Jan 31, 2018